RE:RE:RE:RE:RE:It has to be management
I agree narmac. After all these years of waiting, why get your knickers in a knot now? I'm perfectly (well not perfectly - I'm feeling impatient like the rest of you) willing to wait until revenue comes in rather than giving up anything other than time. My belief is that we will begin to see revenue this quarter. The cost to do a trial without internal funds would be significant. Management has looked into it and have been seriously considering their options for some time now. Why wouldn't they have pulled the trigger already? My guess is they're expecting revenue to help cover the trials. Vaccinex's 1st milestone payment, assuming all went well, should be coming in soon and I would expect much, or at least a good portion of that revenue, to cover much of the cost of taking LSD or MTfp-Trastuzumab into the clinic. Sniper